Ignite Creation Date:
2025-12-24 @ 7:31 PM
Ignite Modification Date:
2026-03-06 @ 8:46 AM
Study NCT ID:
NCT02656303
Status:
TERMINATED
Last Update Posted:
2023-06-22
First Post:
2016-01-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With Umbralisib for Participants Previously Enrolled in Protocol UTX-TGR-304
Sponsor:
TG Therapeutics, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
UTX-TGR-204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None